Nuovopan (Nefopam Hydrochloride)

Nefopam Hydrochloride, the active ingredient in Nuovopan, is a non‑opioid analgesic presented as a 30 mg oral tablet for systemic use. It is employed to manage moderate to severe pain in adult patients when opioid therapy is not appropriate. GNH USA supplies Nuovopan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Nuovopan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nuovopan is a non‑opioid analgesic that acts on the central pain‑modulation pathways to relieve discomfort.

- Post‑operative pain: helps reduce pain intensity after surgical procedures. - Acute musculoskeletal pain: provides analgesia for injuries such as sprains, strains and contusions. - Cancer‑related pain: used as part of a multimodal regimen to control moderate pain in oncology patients.

Adverse reactions to nefopam are generally mild to moderate and vary with individual tolerance.

Common Side Effects: - Nausea: occasional upset stomach and urge to vomit. - Sweating: increased perspiration without exertion. - Dry mouth: reduced salivation leading to a sticky feeling. - Dizziness: light‑headed sensation, especially when standing quickly. - Blurred vision: temporary visual disturbances.

Serious or Rare Side Effects: - Tachycardia: rapid heart rate that may require monitoring. - Seizures: rare occurrence, particularly in patients with a seizure history. - Severe hypotension: marked drop in blood pressure. - Allergic reactions: rash, itching, swelling or anaphylaxis. - Hepatotoxicity: abnormal liver enzyme elevations. - Blood dyscrasias: rare changes in blood cell counts.

When prescribing neforpan, clinicians should assess patient history and monitor for specific risks.

- Renal impairment: adjust monitoring as drug is excreted renally. - Hepatic dysfunction: use caution in patients with liver disease. - Cardiovascular disease: observe for tachycardia or blood pressure changes. - Seizure disorder: avoid or use with caution in individuals with a history of seizures. - Concomitant MAO‑inhibitors: increased risk of hypertensive crisis. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Nefopam may interact with several medication classes; careful review is essential.

Major Interactions (Avoid): - MAO‑inhibitors: risk of hypertensive crisis. - Anticoagulants: enhanced bleeding risk. - Antihypertensives: additive blood‑pressure‑lowering effect.

Moderate Interaction (Monitor Closely): - Tricyclic antidepressants: may increase serotonergic activity. - SSRIs/ SNRIs: potential for serotonin‑together   - Antihistamines - Opioid‑   -